Use of HMGB1 antagonists for the treatment of inflammatory skin conditions

阅读量:

28

申请(专利)号:

US20060988896

申请日期:

2006-07-11

公开/公告号:

US2010040608A1

公开/公告日期:

2010-02-18

申请(专利权)人:

MARIE WAHREN-HERLENIUS;FILIPPA NYBERG;GIOVANNA MARCHINI

发明人:

M Wahren-HerleniusF NybergG Marchini

展开

国省代号:

SE

被引量:

99

摘要:

Methods are disclosed for treating an inflammatory skin condition in a subject. The methods comprise administering to a subject an HMGB antagonist, such as a high mobility group box (HMGB) A box or a biologically active fragment thereof, an antibody to HMGB or an antigen-binding fragment thereof, an HMGB small molecule antagonist, an antibody to TLR2 or an antigen-binding fragment thereof, a soluble TLR2 polypeptide, an antibody to RAGE or an antigen-binding fragment thereof, a soluble RAGE polypeptide and a RAGE small molecule antagonist.

展开

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用